Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 214 entries
View as:

Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01215734 Org: User:
Start: 10/31/10 End: 09/30/12 Due: 09/30/13

Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting

Phase: N/A Priority: Normal
NCT ID: NCT05108805 Org: User:
Start: 12/02/21 End: 12/08/23 Due: 12/08/24

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03206203 Org: User:
Start: 08/29/17 End: 10/04/23 Due: 10/04/24

Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT05764395 Org: User:
Start: 05/09/23 End: 05/01/29 Due: 05/01/30

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06399640 Org: User:
Start: 08/14/24 End: 10/01/27 Due: 10/01/28

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05901545 Org: User:
Start: 08/22/23 End: 11/30/29 Due: 11/30/30

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT02057874 Org: User:
Start: 02/28/14 End: 12/04/15 Due: 12/04/16

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01791478 Org: User:
Start: 04/30/13 End: 02/28/25 Due: 02/28/26

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00633750 Org: User:
Start: 08/31/02 End: 10/31/07 Due: 10/31/08

Inherited CAncer REgistry

Phase: N/A Priority: Normal
NCT ID: NCT03231891 Org: User:
Start: 02/27/17 End: 12/31/35 Due: 12/31/36

PET Imaging of Ovarian Carcinoma With 18F-FSPG

Phase: N/A Priority: Normal
NCT ID: NCT02872519 Org: User:
Start: 06/30/18 End: 08/31/20 Due: 08/31/21

High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT03179761 Org: User:
Start: 10/09/17 End: 10/01/24 Due: 10/01/25

Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked Cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT01141218 Org: User:
Start: 07/31/09 End: 09/30/12 Due: 09/30/13

PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01248494 Org: User:
Start: 11/30/10 End: 05/31/16 Due: 05/31/17

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00639769 Org: User:
Start: 02/28/02 End: 07/31/08 Due: 07/31/09

Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01013506 Org: User:
Start: 08/31/09 End: 12/31/09 Due: 12/31/10

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05501665 Org: User:
Start: 05/09/23 End: 02/01/27 Due: 02/01/28

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00499668 Org: User:
Start: 08/31/07 End: 03/31/08 Due: 03/31/09

Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00343512 Org: User:
Start: 02/29/04 End: 03/31/11 Due: 03/31/12

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Phase: N/A Priority: Normal
NCT ID: NCT06915454 Org: User:
Start: 05/31/25 End: 07/31/27 Due: 07/31/28

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Phase: N/A Priority: Normal
NCT ID: NCT00082667 Org: User:
Start: 10/31/02 End: 06/30/05 Due: 06/30/06

Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01365910 Org: User:
Start: 06/30/11 End: 06/30/13 Due: 06/30/14

Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00611715 Org: User:
Start: 11/30/03 End: 12/31/08 Due: 12/31/09

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06016855 Org: User:
Start: 05/31/24 End: 05/28/28 Due: 05/28/29

Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00664105 Org: User:
Start: 02/29/04 End: 06/30/08 Due: 06/30/09